NO20090027L - Ny analog av vasoaktivt tarmpeptid - Google Patents

Ny analog av vasoaktivt tarmpeptid

Info

Publication number
NO20090027L
NO20090027L NO20090027A NO20090027A NO20090027L NO 20090027 L NO20090027 L NO 20090027L NO 20090027 A NO20090027 A NO 20090027A NO 20090027 A NO20090027 A NO 20090027A NO 20090027 L NO20090027 L NO 20090027L
Authority
NO
Norway
Prior art keywords
vasoactive intestinal
intestinal peptide
new analog
analog
new
Prior art date
Application number
NO20090027A
Other languages
English (en)
Inventor
David Robert Bolin
Wajiha Khan
Hanspeter Michel
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38786842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090027(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20090027L publication Critical patent/NO20090027L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/57563—Vasoactive intestinal peptide [VIP]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

En VPAC-2 reseptor-agonist av formelen [X-(SEKV ID NR: 2)-Y] for behandling av pulmonale obstruktive lidelser, f.eks. KOLS, administrert, f.eks. ved inhalering.
NO20090027A 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid NO20090027L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81880506P 2006-07-06 2006-07-06
PCT/EP2007/056351 WO2008003612A2 (en) 2006-07-06 2007-06-26 Analogs of vasoactive intestinal peptide

Publications (1)

Publication Number Publication Date
NO20090027L true NO20090027L (no) 2009-01-15

Family

ID=38786842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090027A NO20090027L (no) 2006-07-06 2009-01-05 Ny analog av vasoaktivt tarmpeptid

Country Status (20)

Country Link
US (1) US20080096807A1 (no)
EP (1) EP2041168A2 (no)
JP (1) JP2009542593A (no)
KR (1) KR20090027239A (no)
CN (1) CN101484468A (no)
AR (1) AR061825A1 (no)
AU (1) AU2007271274A1 (no)
BR (1) BRPI0714306A2 (no)
CA (1) CA2656757A1 (no)
CL (1) CL2007001956A1 (no)
CR (1) CR10518A (no)
EC (1) ECSP099029A (no)
IL (1) IL196122A0 (no)
MA (1) MA30590B1 (no)
MX (1) MX2009000013A (no)
NO (1) NO20090027L (no)
PE (1) PE20081000A1 (no)
RU (1) RU2009103811A (no)
TW (1) TW200819139A (no)
WO (1) WO2008003612A2 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12012502018A1 (en) 2010-04-30 2018-03-21 Sanwa Kagaku Kenkyusho Co Peptide for improving biostability of bioactive substance, and bioactive substance having improved biostability
CN102827268B (zh) * 2011-06-13 2016-08-24 中肽生化有限公司 新型血管肠肽类似物及其制备方法和用途
US8866872B2 (en) 2011-06-21 2014-10-21 Mitel Networks Corporation Conferencing and collaboration system and methods thereof
WO2014145718A2 (en) * 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
WO2015172046A1 (en) * 2014-05-08 2015-11-12 Phasebio Pharmaceuticals, Inc. Methods and compositions for treating cystic fibrosis
ITUB20159175A1 (it) * 2015-12-23 2017-06-23 Materie Plastiche Pisane S R L Composizione polimerica antibatterica

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879371A (en) * 1971-09-17 1975-04-22 Sami I Said Isolation of vasoactive intestinal peptide
GB8427651D0 (en) * 1984-11-01 1984-12-05 Beecham Group Plc Compounds
GB8525852D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
JPS62246595A (ja) * 1986-04-17 1987-10-27 Eisai Co Ltd 気菅支拡張作用・降圧作用ペプタイド
US4835252A (en) * 1987-02-26 1989-05-30 The Salk Institute Biotechnology/Industrial Associates, Inc. Vasoactive intestinal peptide analogs
AU656230B2 (en) * 1991-10-11 1995-01-27 F. Hoffmann-La Roche Ag Cyclic vasoactive peptides
CN1186355C (zh) * 1996-02-09 2005-01-26 霍夫曼-拉罗奇有限公司 血管活性肠肽类似物的合成
US20050203009A1 (en) * 2004-03-12 2005-09-15 Bayer Pharmaceuticals Corporation VPAC1 selective antagonists and their pharmacological methods of use
EP1781695A1 (en) * 2004-08-18 2007-05-09 Eli Lilly And Company Selective vpac2 receptor peptide agonists
KR20070067136A (ko) * 2004-10-08 2007-06-27 포베스 메디-테크 (리서치) 인코포레이티드 혈관작용성 장내 폴리펩티드 제약

Also Published As

Publication number Publication date
JP2009542593A (ja) 2009-12-03
AU2007271274A1 (en) 2008-01-10
WO2008003612A3 (en) 2008-02-28
MA30590B1 (fr) 2009-07-01
RU2009103811A (ru) 2010-08-20
BRPI0714306A2 (pt) 2014-05-20
KR20090027239A (ko) 2009-03-16
CL2007001956A1 (es) 2008-04-18
AR061825A1 (es) 2008-09-24
ECSP099029A (es) 2009-02-27
TW200819139A (en) 2008-05-01
WO2008003612A2 (en) 2008-01-10
US20080096807A1 (en) 2008-04-24
EP2041168A2 (en) 2009-04-01
CN101484468A (zh) 2009-07-15
CA2656757A1 (en) 2008-01-10
CR10518A (es) 2009-01-27
PE20081000A1 (es) 2008-08-06
MX2009000013A (es) 2009-01-23
IL196122A0 (en) 2011-08-01

Similar Documents

Publication Publication Date Title
MX2009012967A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
MX2009012968A (es) Polipeptidos, dominios variables de anticuerpo y antagonistas.
CY1121543T1 (el) Ενωση πυριδυλαμινοοξεικου οξεος
WO2008051942A3 (en) Farnesoid x receptor agonists
MX2009013990A (es) Metodos para tratar enfermedades y trastornos mediados por serotonina.
WO2008082613A3 (en) Factor ix moiety-polymer conjugates having a releasable linkage
TW200738632A (en) Cannabinoid receptor modulators
WO2010042543A3 (en) Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto
WO2006117299A3 (en) Novel crystalline forms of tiotropium bromide
MY153957A (en) Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates
DK1718336T3 (da) Ny kombination af anticholinergikum og beta-mimetika til behandling af luftvejssygdomme
WO2007076260A3 (en) Farnesoid x receptor agonists
MX2011008799A (es) Polipeptidos, dominios variables de anticuerpos, y antagonistas anti-tnfr1 mejorados.
WO2012110770A3 (en) Combination of glycopyrrolate and a beta2 -agonist
WO2008070111A3 (en) Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof
WO2009053339A3 (en) Cholesterol derivatives of inhibitors of viral fusion
WO2010048477A3 (en) Improved process for preparation of coupled products from 4-amino-3-cyanoquinolines using stabilized intermediates
MX2009007911A (es) Inhibidores de proteina tirosina fosfatasa 1b aromaticos fusionados.
WO2006117300A3 (en) Crystalline forms of tiotropium bromide
WO2008003612A3 (en) Analogs of vasoactive intestinal peptide
MY162095A (en) Method of treating symptoms of hormonal variations
MX2009008527A (es) Compuestos de amonio cuaternario y difenilmetilo utiles como antagonistas del receptor muscarinico.
TW200800979A (en) Halogenated sulfonamide derivatives
WO2007079163A3 (en) Prokineticin 1 receptor antagonists
TW200720236A (en) Organic compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application